Overview
Valued at ~$234 million in 2023, the atrial septal defect (ASD) closure devices market is
projected to reach ~$294 million by 2028, increasing at a CAGR of 4.6% over
the 2023-2028 forecast period. This Market Snapshot is part of LSI’s Market Intelligence platform, your
one-stop-shop for global medtech market sizing and analysis, procedure volume data, startup company- and
deal-tracking, curated insights, and more.
Atrial septal occlusion devices, often referred to as ASD closure devices, are used to close an abnormal hole in
the wall of the upper chambers of the heart. While small ASDs may close on their own, larger defects require
surgical repair.
Products included within the scope of this analysis include:
Implantable atrial septal occlusion devices
This Market Snapshot is intended to provide a high-level overview of the global market for ASD closure devices,
with key insights into:
Unit volumes from 2023 to 2028
Market forecasts from 2023 to 2028
Market insights
Competitive landscape analysis of major competitors
Insights into key market events for strategic and startups
ASD Closure Devices Market Snapshot Summary
| Snapshot Aspect | Data and Details |
| Base Year for Estimate | 2023 |
| Forecast Period | 2023 - 2028 |
| Market Size in 2023 | $234 million |
| CAGR | 4.6% |
| Projected Market Size in 2028 | $294 million |
ASD Closure Devices Market Insights
The ASD closure devices market is driven by two main factors: the steady increase in the global population and
improvements in closure device technology. Together, these factors result in increasing levels of utilization
and increasing prices. Innovations, like the GoreⓇ Cardioform Atrial Septal Defect Occluder (C-ASDO), are
expanding treatment options by offering a wider range of sizes for closing ASDs, driving higher device
utilization.
Additionally, both the Gore Cardioform and Abbott Amplatzer devices are FDA-approved for closing Patent Foramen
Ovale (PFO), significantly expanding the potential market for transcatheter closure devices. However, it is
important to note that PFO closure procedures are not included in ASD market estimates, though they contribute
to the growth of the broader device segment.
Competitive Landscape
The full Market Snapshot includes a robust analysis of the competitive landscape for the ASD closure devices
market. This includes estimated market revenue and market share for key players, such as Abbott, W.L. Gore, and
Occlutech.
Select Market Events
| Company | Date | Event Type | Event |
|
Abbott
|
7/2023 | Product Recall | Abbott recalled 672 Amplatzer™ Steerable Delivery Sheaths in a Class I recall due to an increased risk of air embolism. |
|
Occlutech
|
1/2024 | Regulatory | Occlutech announced FDA approval of two new ASD treatment devices: the OcclutechⓇ ASD Occluder and the OcclutechⓇ Pistol Pusher. |
Key Companies Covered
Abbott
atHeart Medical
Lifetech Scientific
Lepu Medical
Occlutech
W.L. Gore
